 Monopar Therapeutics Inc. today announced the closing of its initial public offering of 1,277,778 shares of common stock, including the underwriters exercise of its over-allotment option, at a public offering price of 8.00 per share before underwriting discounts and commissions. Total net proceeds, after deducting underwriting discounts and commissions and estimated offering expenses, are approximately 9.3 million from the initial public offering. JonesTrading Institutional Services LLC acted as Lead Bookrunning Manager and Brookline Capital Markets, a division of Arcadia Securities, LLC, acted as Co-Manager for the offering. 